Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 9Phase 1 9Phase 3 2Phase 2/3 1

Status

Recruiting 23Not yet recruiting 7Unknown 3Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Treatment-naive Advanced Non-small Cell Lung Cancer 1Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × toripalimab × Clear all
NCT03829969 2025-07-23

JUPITER06

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
514 enrolled 22 charts
Gastrointestinal

Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy

NCT03856411 2023-02-01

A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
465 enrolled
Thoracic

Treatment-naive Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡